Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial:a double-blind, active and placebo-controlled study

Autoria(s): Diener, Hans-Christoph; Sacco, Ralph L; Yusuf, Salim; Cotton, Daniel; Ounpuu, Stephanie; Lawton, William A; Palesch, Yuko; Martin, Reneé H; Albers, Gregory W; Bath, Philip; Bornstein, Natan; Chan, Bernard P L; Chen, Sien-Tsong; Cunha, Luis; Dahlöf, Björn; De Keyser, Jacques; Donnan, Geoffrey A; Estol, Conrado; Gorelick, Philip; Gu, Vivian; Hermansson, Karin; Hilbrich, Lutz; Kaste, Markku; Lu, Chuanzhen; Machnig, Thomas; Pais, Prem; Roberts, Robin; Skvortsova, Veronika; Teal, Philip; Toni, Danilo; VanderMaelen, Cam; Voigt, Thor; Weber, Michael; Yoon, Byung-Woo; Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) study group; Passmore, Peter
Data(s)

01/10/2008
Resumo

The treatment of ischaemic stroke with neuroprotective drugs has been unsuccessful, and whether these compounds can be used to reduce disability after recurrent stroke is unknown. The putative neuroprotective effects of antiplatelet compounds and the angiotensin II receptor antagonist telmisartan were investigated in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial.
Identificador

http://pure.qub.ac.uk/portal/en/publications/effects-of-aspirin-plus-extendedrelease-dipyridamole-versus-clopidogrel-and-telmisartan-on-disability-and-cognitive-function-after-recurrent-stroke-in-patients-with-ischaemic-stroke-in-the-prevention-regimen-for-effectively-avoiding-second-strokes-profess-trial(a18213b0-ae57-45e8-a447-a2b546a010ef).html

http://dx.doi.org/10.1016/S1474-4422(08)70198-4
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Diener , H-C , Sacco , R L , Yusuf , S , Cotton , D , Ounpuu , S , Lawton , W A , Palesch , Y , Martin , R H , Albers , G W , Bath , P , Bornstein , N , Chan , B P L , Chen , S-T , Cunha , L , Dahlöf , B , De Keyser , J , Donnan , G A , Estol , C , Gorelick , P , Gu , V , Hermansson , K , Hilbrich , L , Kaste , M , Lu , C , Machnig , T , Pais , P , Roberts , R , Skvortsova , V , Teal , P , Toni , D , VanderMaelen , C , Voigt , T , Weber , M , Yoon , B-W , Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) study group & Passmore , P 2008 , ' Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial : a double-blind, active and placebo-controlled study ' Lancet Neurology , vol 7 , no. 10 , pp. 875-84 . DOI: 10.1016/S1474-4422(08)70198-4
Palavras-Chave #/dk/atira/pure/subjectarea/asjc/2700/2728 #Clinical Neurology
Tipo

article
Acesso ao item digital